P. Victor Schut, Chief Business Officer at AGILeBiotics, is an entrepreneur and experienced CEO/Chief Business Officer with a demonstrated history of working in the biotechnology industry over the past 17 years.
At AGILeBiotics, he is responsible for securing funding for the next development stages, i.e. pre-clinical and Phase I studies for the company’s lead antibiotic candidates. Before joining AGILeBiotics he co-founded ProteoNic and served at the company as its CEO and CBO for 15 years. He is co-founder/CEO of Mycology Solutions active in developing treatment for multidrug-resistant fungal infections and operates as independent consultant coaching several biotech start-ups (strategy, business development and funding). Prior to entering the biotech sector, he was active as banker and as investment manager at private equity fund Antea Participaties. He holds a master degree in corporate law from the University of Leiden.